Commission Implementing Regulation (EU) 2023/741 of 5 April 2023 concerning the non-renewal of the approval of the active substance oxamyl, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance)
| Amendments and corrections | |
|---|---|
| May 1, 2023 | Entry into force - Date pub. +20 See Art 5 |
| April 14, 2023 | Corrected by 32023R0741R(01) |
| Consolidated texts | ||
|---|---|---|
| April 11, 2023 | Modified by 32023R0741 32023R0741R(01) | 02023R0741-20230411 |
| April 11, 2023 | Date of publication | 32023R0741 |